‹ ›
MYP_040959
Basic Information
Unnamed
Anticancer
Antimicrobial
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Wound healing/Regeneration ▸ Angiogenesis modulation ▸ Anti-angiogenic
Standard
19 amino acids
C81H127N27O30S2
Standard
Sequence
GPWEDCSVSCGGGEQLRSR
Physicochemical Analysis
2023.17 Da
4.68
-1.25
-1.49
-0.0659
-0.87
0.36
-0.17
97.81
35.79
0.0526
5500.00
5625.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
933.60
-13.58
35.0
31.0
65.0
140.0
3.0
19.0
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T23:34:32.539617+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0417635 REVIEWED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Thrombospondin type-1 repeat
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anti-angiogenic
Homo sapiens (human umbilical vein endothelial cells, HUVECs)
70 % control-scaled migration inhibition
Modified Boyden chamber VEGF-stimulated HUVEC migration inhibition (20 h; reported response)
Showing 1 records · Page 2 of 2